🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate if the study vaccine, m-IPV2 HD...
Status
Completed
Location
Ghent University Hospital
Start Date
2013-11
Trial ID
NCT01997632
DTPa and IPV vaccines are recommended for immunization of infants in Korea....
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-01
Trial ID
NCT00290342
Treatments Being Tested
The purpose of the study is to evaluate immunogenicity and safety of three ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT04073459
Treatments Being Tested
In this study, the safety and tolerability of inactivated polio vaccine (IP...
Status
Completed
Location
University of Antwerpen
Start Date
2020-01-22
Trial ID
NCT04232943
Primary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
The aim of the study is to assess the immunogenicity of SP059 (IMOVAX POLIO...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02005536
Treatments Being Tested
The purpose of the study is to evaluate safety and immunogenicity of inacti...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2017-05-31
Trial ID
NCT03169725
The purpose of this study is to generate data to support the registration e...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01475539